Indications and uses
reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.
reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.
adults and children 12 years of age and over take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor
Allegra Hives 24HR tablet 180 mg
Drug Facts
Fexofenadine HCl 180 mg
Antihistamine
reduces hives and relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.
Severe Allergy Warning: Get emergency help immediately if you have hives along with any of the following symptoms:
■ trouble swallowing ■ dizziness or loss of consciousness ■ swelling of tongue
■ swelling in or around mouth ■ trouble speaking ■ wheezing or problems breathing ■ drooling
These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health professional immediately. Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later.
Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrine injector for “anaphylaxis” or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times.
■ to prevent hives from any known cause such as:
■ foods ■ insect stings ■ medicines ■ latex or rubber gloves because this product will not stop hives from occurring. Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a cause.
■ if you have ever had an allergic reaction to this product or any of its ingredients.
■ kidney disease. Your doctor should determine if you need a different dose.
■ hives that are an unusual color, look bruised or blistered
■ hives that do not itch
■ do not take more than directed
■ do not take at the same time as aluminum or magnesium antacids
■ do not take with fruit juices (see Directions)
■ an allergic reaction to this product occurs. Seek medical help right away.
■ symptoms do not improve after 3 days of treatment
■ the hives have lasted more than 6 weeks
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours |
| children under 12 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
■(if blister) safety sealed: do not use if carton is opened or if individual blister units are torn or opened
■(on the carton if bottle) safety sealed: do not use if carton is opened or if printed foil inner seal on bottle is torn or missing
■(if bottle) safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
■ store between 20° and 25°C (68° and 77°F)
■ protect from excessive moisture
colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide blends, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, titanium dioxide
call toll-free 1-800- 633-1610
Allegra
Hives
fexofenadine HCI tablet
180 mg/antihistamine
24 HR
30 TABLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 997422 | Allegra 180 MG Oral Tablet | PSN | 10 |
| 997420 | fexofenadine HCl 180 MG 24 HR Oral Tablet | PSN | 10 |
| 997422 | fexofenadine hydrochloride 180 MG Oral Tablet [Allegra] | SBD | 10 |
| 997420 | fexofenadine hydrochloride 180 MG Oral Tablet | SCD | 10 |
| 997422 | Allegra 180 MG Oral Tablet | SY | 10 |
| 997420 | fexofenadine HCl 180 MG 24 HR Oral Tablet | SY | 10 |
| Class | Version | Type | Effective |
|---|---|---|---|
| FEXOFENADINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code | allegra-hives-24hr-01.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-4126-3 | Allegra Hives 24hr | 15 in 1 BOTTLE | TABLET, FILM COATED | 15 | 10 | |
| 41167-4126-3 | Allegra Hives 24hr | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 10 | |
| 41167-4126-4 | Allegra Hives 24hr | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 10 | |
| 41167-4126-4 | Allegra Hives 24hr | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 10 | |
| 41167-4126-8 | Allegra Hives 24hr | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 10 | |
| 41167-4126-8 | Allegra Hives 24hr | 5 in 1 BLISTER PACK | TABLET, FILM COATED | 5 | 10 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-4126-4 | EA - Each | 41167-4126 | 2e2fdad2-f58a-4b50-9a4b-db9122adef32 | 1 | 2023-05-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-4126 | 41167-4126-8, 41167-4126-3, 41167-4126-4 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 9 | 2024-06-01 | full-release | 2026-06-01 00:39:15 |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020872-005 | CHILDREN'S ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | |
| N020872-006 | CHILDREN'S ALLEGRA HIVES | FEXOFENADINE HYDROCHLORIDE | 30MG | TABLET / ORAL | RLD | 2011-01-24 | |
| N020872-007 | ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | 60MG | TABLET / ORAL | RLD | 2011-01-24 | |
| N020872-008 | ALLEGRA HIVES | FEXOFENADINE HYDROCHLORIDE | 60MG | TABLET / ORAL | RLD | 2011-01-24 | |
| N020872-009 | ALLEGRA HIVES | FEXOFENADINE HYDROCHLORIDE | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | |
| N020872-010 | ALLEGRA ALLERGY | FEXOFENADINE HYDROCHLORIDE | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-009 | ALLEGRA HIVES | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020872-010 | ALLEGRA ALLERGY | 180MG | TABLET / ORAL | RLD, RS | 2011-01-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020872-005 | CHILDREN'S ALLEGRA ALLERGY | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2011-01-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020872-006 | CHILDREN'S ALLEGRA HIVES | 30MG | TABLET / ORAL | RLD | 2011-01-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020872-007 | ALLEGRA ALLERGY | 60MG | TABLET / ORAL | RLD | 2011-01-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020872-008 | ALLEGRA HIVES | 60MG | TABLET / ORAL | RLD | 2011-01-24 | fd3edfee7708… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allegra Hives 24hr | FEXOFENADINE HYDROCHLORIDE | Chattem, Inc. | 490b4c5f-448b-4563-928b-837117b59b9f | 2026-01-12 | Warnings | 41167-4126-8 41167-4126-3 41167-4126-4 41167-4126 41167412604 41167412603 41167412608 942f38c8-c652-49b9-b98f-e8edcf66db1c 490b4c5f-448b-4563-928b-837117b59b9f |
Adverse event summaries are temporarily unavailable. Other product information remains available.